USA
AGIC exits healthcare business Ritedose to Novo Holdings
AGIC Capital, which specializes in cross-border deals along the China-Europe axis, has agreed to sell pharmaceutical manufacturing and packaging business Ritedose Corporation to Novo Holdings.
ADV backs Asia, North America flooring manufacturer
ADV Partners has acquired a significant minority interest in CFL Technologies, a flooring materials business with a presence in multiple locations in the US, China, and Vietnam.
2022 preview: Macro & buyout
Will the bullish investment environment persist through 2022? Most Asia-based private equity players expect to remain busy, although they acknowledge a lack of visibility around macro and geopolitical risk
Blue Owl buys Asia-based placement agent
US alternative asset manager Blue Owl Capital has acquired Hong Kong placement agent Ascentium with a view to establishing a physical presence in the territory and pursuing a broader regional expansion.
China's Didi to delist in New York
China ride-hailing platform Didi, which has traded poorly ever since being targeted by regulators in the wake of its IPO in June, plans to delist from the New York Stock Exchange and relist in Hong Kong.
Apollo prioritizes yield, hybrid strategies in Asia - AVCJ Forum
Apollo Global Management’s yield and hybrid businesses – rather than private equity – are likely to account for the bulk of its activity in Asia, with Marc Rowan, the firm’s co-founder and CEO, saying he has no desire to “add to the growing...
Japan's Olympus launches VC unit, $50m fund
Japan’s Olympus Corporation has launched a medical technology-focused venture capital unit, Olympus Innovation Ventures, with an initial commitment of $50 million for its debut fund.
Q&A: Thoma Bravo’s Orlando Bravo
Orlando Bravo, founder and managing partner of Thoma Bravo, which claims to be the largest PE investor in software globally, on SaaS in a post-COVID-19 world, the rise of blockchain, and opportunities in Asia
Q&A: 500 Global’s Christine Tsai
Christine Tsai, co-founder of 500 Global, formerly 500 Startups, reflects on how a planetary approach to seed-stage VC has changed the asset class, the developing world, and the firm itself
Temasek leads $550m round for US cybersecurity player Orca
Singapore’s Temasek Holdings has led a $550 million Series C round for US cybersecurity provider Orca Security that will support an Asia expansion.
China SaaS: Path to profitability
COVID-19 has driven enterprise uptake of software-as-a-service solutions in China, but paying customers are still relatively few. Other markets offer some pointers on monetization
Pacific Century’s insurtech business extends Series A to $210m
Pacific Century Group’s insurance technology business, Bolttech, has extended a recent $180 million Series A round to $210 million in total.
India's Freshworks flourishes on NASDAQ debut
Freshworks, one of India's leading software-as-a-service (SaaS) businesses, traded strongly on its NASDAQ debut following a $1 billion IPO.
500 Startups closes $140m global fund, rebrands
500 Startups has closed its largest-ever global fund at $140 million, while simultaneously rebranding as 500 Global and expanding its strategy to include later-stage deals.
India's FreshWorks targets $912m US IPO
Freshworks, which earlier this year lost its status as India’s most valuable software-as-a-service (SaaS) start-up, is looking to raise up to $912 million through a US IPO.
China take-privates: Holding pattern
Pressure is mounting on Chinese companies listed in New York, from domestic and US regulators. Is another wave of PE-backed take-privates imminent?
China-focused NFT marketplace Cybertino raises $10m
A group of Chinese investors including Sky9 Capital, Ince Capital, and Draper Dragon have joined a $10 million round for non-fungible token (NFT) marketplace Cybertino Lab.
Japan's Shiseido sells US makeup brands to Advent
Japan’s Shiseido has extended a program of non-core divestments with the sale of three of its US makeup brands to Advent International for $700 million.
Sherpa Healthcare leads Series A for Paq Therapeutics
Sherpa Healthcare Partners has led a $30 million Series A for Paq Therapeutics, a Chinese-founded biotech company specializing in treatments based on molecules that enhance the degradation of disease-causing entities.
SOSV raises $100m growth fund
Early-stage investor SOSV – known for accelerator programs such as China-based HAX and Chinaccelerator – has raised $100 million for its first growth fund designed to invest in Series B rounds and beyond.
Australia's PEP to exit investor services business AST
Pacific Equity Partners (PEP) is poised to exit American Stock Transfer & Trust (AST), its longest-held portfolio company, following an agreement to sell the business to US-based Siris Capital.
Pacific Century's insurtech business closes $180m Series A
Bolttech, a one-year-old company controlled by Pacific Century Group, has raised $180 million at a valuation of $1 billion. It is being called the largest-ever Series A round in insurance technology.
VC-backed Australia cloud business sold to US strategic
Panviva, an Australian cloud-based enterprise software provider backed by a number of venture capital investors, has been acquired by US counterpart Upland Software for about $23.3 million.
NewQuest exits BPO business to US GP
NewQuest Capital Partners is exiting Integreon, a business process outsourcing (BPO) provider with a significant Asia footprint to US private equity firm EagleTree Capital.